Learning Objectives: (Dr. Howard)

1. Disccus the role of adjuvant chemoradiation in head and neck cancer

2. Comparie effectiveness of treatment regimens using observational data

3. Utilize machine learning to personalize treatment of resected head and neck cancer

 

Learning Objectives: (Dr. Yu)

1. Review of adverse events in adoptive cell therapy

2. Overview of current management of cytokine relase syndrome (CRS) and imune effector cell-associated neurotoxicity syndrome (ICANS)

3. Exporation of novel therapies to manage and reduce adverse events.

Session date: 
Monday, May 4, 2020 - 12:00pm to 1:00pm
Speaker Name: 
Jovian Yu, MD and Frederick M. Howard, MD
Location: 
UCMC
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.